NO20071485L - Kjemiske substanser. - Google Patents
Kjemiske substanser.Info
- Publication number
- NO20071485L NO20071485L NO20071485A NO20071485A NO20071485L NO 20071485 L NO20071485 L NO 20071485L NO 20071485 A NO20071485 A NO 20071485A NO 20071485 A NO20071485 A NO 20071485A NO 20071485 L NO20071485 L NO 20071485L
- Authority
- NO
- Norway
- Prior art keywords
- chemical substances
- fatty acid
- acid derivatives
- unsaturated fatty
- relates
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/0026—Oxygen-containing hetero ring cyclic ketals
- C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Endocrinology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Den foreliggende oppfinnelsen vedrører visse umettede fettsyrederivater av terapeutisk aktive glukokortikostereoider og farmasøytiske formuleringer som inneholder slike.
Priority Applications (17)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO20071485A NO331891B1 (no) | 2007-03-20 | 2007-03-20 | Kjemiske forbindelser, et farmasoytisk preparat inneholdende slike forbindelser, samt anvendelse derav for behandling av kreft, inflammasjon og KOLS |
CA002680155A CA2680155A1 (en) | 2007-03-20 | 2008-03-13 | Fatty acid esters of glucocorticoids as anti-inflammatory and anti-cancer agents |
EP08741696A EP2121723A2 (en) | 2007-03-20 | 2008-03-13 | Fatty acid esters of glucocorticoids as anti-inflammatory and anti-cancer agents |
US12/531,214 US9428540B2 (en) | 2007-03-20 | 2008-03-13 | Fatty acid esters of glucocorticoids as anti-inflammatory and anti-cancer agents |
RU2009138488/04A RU2462472C2 (ru) | 2007-03-20 | 2008-03-13 | Химические соединения |
UAA200910594A UA96794C2 (ru) | 2007-03-20 | 2008-03-13 | Глюкокортикоиды, способ их применения, способ лечения и фармацевтическая композиция на их основе |
JP2010500862A JP2010522233A (ja) | 2007-03-20 | 2008-03-13 | 抗炎症剤及び抗癌剤であるグルココルチコイドの脂肪酸エステル |
KR1020097021890A KR20090123961A (ko) | 2007-03-20 | 2008-03-13 | 항염증제 및 항암제로서 글루코코르티코이드의 지방산 에스테르 |
NZ579382A NZ579382A (en) | 2007-03-20 | 2008-03-13 | Fatty acid esters of glucocorticoids as anti-inflammatory and anti-cancer agents |
CN200880008837A CN101687904A (zh) | 2007-03-20 | 2008-03-13 | 作为抗炎和抗癌药剂的糖皮质激素的脂肪酸脂 |
AU2008227246A AU2008227246B2 (en) | 2007-03-20 | 2008-03-13 | Fatty acid esters of glucocorticoids as anti-inflammatory and anti-cancer agents |
PCT/NO2008/000096 WO2008115069A2 (en) | 2007-03-20 | 2008-03-13 | Fatty acid esters of glucocorticoids as anti-inflammatory and anti-cancer agents |
MX2009009838A MX2009009838A (es) | 2007-03-20 | 2008-03-13 | Esteres de acidos grasos de glucocorticoides como agentes antiinflamatorios y anti-cancer. |
TW097109460A TWI428133B (zh) | 2007-03-20 | 2008-03-18 | 作為抗發炎劑及抗癌劑之糖皮質素的脂肪酸酯 |
IL200655A IL200655A0 (en) | 2007-03-20 | 2009-08-31 | Fatty acid esters of glucocorticoids as anti-inflammatory and anti-cancer agents |
ZA200906226A ZA200906226B (en) | 2007-03-20 | 2009-09-08 | Fatty acid esters of glucocorticoids as anti-inflammatory and anti-cancer agents |
JP2013105719A JP2014012657A (ja) | 2007-03-20 | 2013-05-20 | 抗炎症剤及び抗癌剤であるグルココルチコイドの脂肪酸エステル |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO20071485A NO331891B1 (no) | 2007-03-20 | 2007-03-20 | Kjemiske forbindelser, et farmasoytisk preparat inneholdende slike forbindelser, samt anvendelse derav for behandling av kreft, inflammasjon og KOLS |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20071485L true NO20071485L (no) | 2008-09-22 |
NO331891B1 NO331891B1 (no) | 2012-04-30 |
Family
ID=39734182
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20071485A NO331891B1 (no) | 2007-03-20 | 2007-03-20 | Kjemiske forbindelser, et farmasoytisk preparat inneholdende slike forbindelser, samt anvendelse derav for behandling av kreft, inflammasjon og KOLS |
Country Status (16)
Country | Link |
---|---|
US (1) | US9428540B2 (no) |
EP (1) | EP2121723A2 (no) |
JP (2) | JP2010522233A (no) |
KR (1) | KR20090123961A (no) |
CN (1) | CN101687904A (no) |
AU (1) | AU2008227246B2 (no) |
CA (1) | CA2680155A1 (no) |
IL (1) | IL200655A0 (no) |
MX (1) | MX2009009838A (no) |
NO (1) | NO331891B1 (no) |
NZ (1) | NZ579382A (no) |
RU (1) | RU2462472C2 (no) |
TW (1) | TWI428133B (no) |
UA (1) | UA96794C2 (no) |
WO (1) | WO2008115069A2 (no) |
ZA (1) | ZA200906226B (no) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8497292B2 (en) | 2005-12-28 | 2013-07-30 | Translational Therapeutics, Inc. | Translational dysfunction based therapeutics |
NO331891B1 (no) | 2007-03-20 | 2012-04-30 | Clavis Pharma Asa | Kjemiske forbindelser, et farmasoytisk preparat inneholdende slike forbindelser, samt anvendelse derav for behandling av kreft, inflammasjon og KOLS |
GB201006181D0 (en) | 2010-04-14 | 2010-06-02 | Ayanda As | Composition |
PT105723B (pt) * | 2011-05-26 | 2014-03-24 | Hovione Farmaci Ncia S A | Método para a preparação de compostos orgânicos biologicamente activos |
US9155747B2 (en) * | 2012-09-13 | 2015-10-13 | Chiesi Farmaceutici S.P.A. | Isoxazolidine derivatives |
AU2017274442B2 (en) | 2016-06-02 | 2021-08-19 | Abbvie Inc. | Glucocorticoid receptor agonist and immunoconjugates thereof |
JPWO2018159808A1 (ja) * | 2017-03-03 | 2019-12-26 | 国立研究開発法人国立がん研究センター | 抗il−7r抗体の抗体薬物コンジュゲートと、がんまたは炎症を処置することに用いるための、抗il−7r抗体と細胞傷害剤との抗体薬物コンジュゲートを含む医薬組成物 |
CN108659090A (zh) * | 2017-03-31 | 2018-10-16 | 天津药业研究院有限公司 | 一种17β-硫代羧酸氯甲酯类甾体化合物的制备方法 |
EP3884962A1 (en) | 2017-12-01 | 2021-09-29 | AbbVie Inc. | Glucocorticoid receptor agonist and immunoconjugates thereof |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1227992A (no) * | 1968-01-23 | 1971-04-15 | Koninklijke Gist Spiritus | |
IT1043956B (it) * | 1970-10-17 | 1980-02-29 | Isf Spa | 21 esteri di acidi grassi insaturi del desa e beta metazone |
JPS56138200A (en) * | 1980-02-15 | 1981-10-28 | Glaxo Group Ltd | Androstane carbothioate compound |
SE8403905D0 (sv) * | 1984-07-30 | 1984-07-30 | Draco Ab | Liposomes and steroid esters |
JPH0381286A (ja) * | 1989-08-22 | 1991-04-05 | Green Cross Corp:The | ステロイド外用剤 |
JPH05132498A (ja) * | 1991-11-08 | 1993-05-28 | Asahi Glass Co Ltd | ステロイド誘導体およびその製剤 |
GB2321455A (en) * | 1997-01-24 | 1998-07-29 | Norsk Hydro As | Lipophilic derivatives of biologically active compounds |
AU2001242879A1 (en) | 2000-03-24 | 2001-10-03 | Dsm N.V. | Radiation-curable coatings suitable for high-speed application onto optical fibers |
GB0017988D0 (en) * | 2000-07-21 | 2000-09-13 | Glaxo Group Ltd | Novel process |
GB0202563D0 (en) * | 2002-02-04 | 2002-03-20 | Glaxo Group Ltd | Process |
US20040235811A1 (en) * | 2002-10-08 | 2004-11-25 | Sepracor Inc. | Fatty acid modified forms of glucocorticoids |
NO331891B1 (no) | 2007-03-20 | 2012-04-30 | Clavis Pharma Asa | Kjemiske forbindelser, et farmasoytisk preparat inneholdende slike forbindelser, samt anvendelse derav for behandling av kreft, inflammasjon og KOLS |
-
2007
- 2007-03-20 NO NO20071485A patent/NO331891B1/no not_active IP Right Cessation
-
2008
- 2008-03-13 RU RU2009138488/04A patent/RU2462472C2/ru not_active IP Right Cessation
- 2008-03-13 US US12/531,214 patent/US9428540B2/en not_active Expired - Fee Related
- 2008-03-13 AU AU2008227246A patent/AU2008227246B2/en not_active Ceased
- 2008-03-13 CN CN200880008837A patent/CN101687904A/zh active Pending
- 2008-03-13 MX MX2009009838A patent/MX2009009838A/es active IP Right Grant
- 2008-03-13 EP EP08741696A patent/EP2121723A2/en not_active Withdrawn
- 2008-03-13 NZ NZ579382A patent/NZ579382A/en not_active IP Right Cessation
- 2008-03-13 WO PCT/NO2008/000096 patent/WO2008115069A2/en active Application Filing
- 2008-03-13 JP JP2010500862A patent/JP2010522233A/ja active Pending
- 2008-03-13 KR KR1020097021890A patent/KR20090123961A/ko not_active Application Discontinuation
- 2008-03-13 CA CA002680155A patent/CA2680155A1/en not_active Abandoned
- 2008-03-13 UA UAA200910594A patent/UA96794C2/ru unknown
- 2008-03-18 TW TW097109460A patent/TWI428133B/zh not_active IP Right Cessation
-
2009
- 2009-08-31 IL IL200655A patent/IL200655A0/en unknown
- 2009-09-08 ZA ZA200906226A patent/ZA200906226B/xx unknown
-
2013
- 2013-05-20 JP JP2013105719A patent/JP2014012657A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
MX2009009838A (es) | 2010-01-15 |
WO2008115069A3 (en) | 2008-11-13 |
RU2462472C2 (ru) | 2012-09-27 |
JP2010522233A (ja) | 2010-07-01 |
AU2008227246A1 (en) | 2008-09-25 |
TWI428133B (zh) | 2014-03-01 |
KR20090123961A (ko) | 2009-12-02 |
JP2014012657A (ja) | 2014-01-23 |
WO2008115069A2 (en) | 2008-09-25 |
NO331891B1 (no) | 2012-04-30 |
US20100099654A1 (en) | 2010-04-22 |
NZ579382A (en) | 2011-09-30 |
US9428540B2 (en) | 2016-08-30 |
AU2008227246B2 (en) | 2012-06-14 |
EP2121723A2 (en) | 2009-11-25 |
UA96794C2 (ru) | 2011-12-12 |
RU2009138488A (ru) | 2011-04-27 |
TW200846010A (en) | 2008-12-01 |
CN101687904A (zh) | 2010-03-31 |
ZA200906226B (en) | 2010-05-26 |
IL200655A0 (en) | 2010-05-17 |
CA2680155A1 (en) | 2008-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20071485L (no) | Kjemiske substanser. | |
NO20073601L (no) | Immunresponsmodifikator-skumformuleringer | |
CY1123549T1 (el) | Σταθερη φαρμακευτικη συνθεση και μεθοδοι χρησης αυτης | |
MY142589A (en) | Benzimidazole derivatives : preparation and pharmaceutical applications | |
UY29395A1 (es) | Formulación de medicamentos conteniendo vardenafilo. | |
EA201270666A1 (ru) | Соединения и фармацевтические композиции для снижения уровня мочевой кислоты | |
CR20110599A (es) | Composiciones farmacéuticamente activas que comprenden moduladores de estrés oxidativo (osm), nuevas entidades químicas, composiciones y usos | |
MA32200B1 (fr) | Nouvelles formulations,comprimes comprenant de telles formulations, leur utilisation et leur procede de preparation | |
FR2902007B1 (fr) | Formulations pharmaceutiques pour la liberation prolongee de principe(s) actif(s) ainsi que leurs applications notamment therapeutiques | |
EA201170508A1 (ru) | Производные 1-амино-2-циклобутилэтилбороновой кислоты | |
ECSP088214A (es) | Formulaciones de acetato de bazedoxifeno que tienen una conversión polimórfica reducida | |
CR10479A (es) | Modulares bencimidazolicos de vr1 | |
EA200800360A1 (ru) | Формуляции с высоким содержанием лекарства и дозированные формы | |
CL2012001836A1 (es) | Compuestos de pirazol, antagonista de crth2; composicion farmacéutica; uso en el tratamiento de trastornos inflamatorios, infecciosos, inmunoreguladores, enfermedades respiratorias, gastrointestinales o dolencias, entre otros. | |
NO20083905L (no) | Nye pyron-indol derivater og fremgangsmate for deres fremstilling | |
MX2012005689A (es) | Analogos de acido araquidonico y metodos para el tratamiento analgesico utilizando los mismos. | |
WO2011161396A3 (en) | Disinfectant composition | |
WO2011006935A3 (en) | Tetrazole derivatives | |
BR112012029697A2 (pt) | polissacarídeo da semente de tamarindo para uso no tratamento de doenças inflamatórias | |
AR070392A1 (es) | Composiciones de tabletas de ranitidina de desintegracion oral y sus metodos de eleboracion | |
CY1107277T1 (el) | Βενζισοξαζολες | |
GT200800178A (es) | Asociacion entre un antiaterotrombotico y un inhibidor de la enzima de conversion de la angiotensina | |
MA55298A (fr) | Compositions pharmaceutiques contenant des anticorps anti-lingo-1 | |
ECSP099801A (es) | COMPOSICIÓN FARMACÉUTICA QUE COMPRENDE LA COMBINACIÓN DE UN AGENTE INHIBIDOR DE LA ENZIMA HMG-CoA REDUCTASA Y UN AGENTE INHIBIDOR DE LA ENZIMA LIPASA GASTROINTESTINAL | |
BR112015000647A2 (pt) | composições orais líquidas e pediátricas que contêm nepadutant |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |